Insulet
PODD
$189.09
Share price
0.09%
Change (1 day)
-36.84%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Insulet (PODD) - Total debt
Total debt on the balance sheet as of September 2023 : $1.42 B
According to Insulet's latest financial reports the company's total debt is $1.42 B. A company’s total debt is the sum of all current and non-current debts.
Insulet - Total debt on balance sheet (from 2005 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $1.40 B | 12.25% |
| 2021-12-31 | $1.24 B | 19.65% |
| 2020-12-31 | $1.04 B | 17.55% |
| 2019-12-31 | $0.88 B | 49.99% |
| 2018-12-31 | $0.59 B | 4.56% |
| 2017-12-31 | $0.56 B | 70% |
| 2016-12-31 | $0.33 B | 87.64% |
| 2015-12-31 | $0.17 B | 1.63% |
| 2014-12-31 | $0.17 B | 43.52% |
| 2013-12-31 | $0.12 B | 2.98% |
| 2012-12-31 | $0.11 B | 8.86% |
| 2011-12-31 | $0.10 B | 56.32% |
| 2010-12-31 | $69.43 M | -28.4% |
| 2009-12-31 | $96.97 M | 14.09% |
| 2008-12-31 | $85 M | 218.63% |
| 2007-12-31 | $26.67 M | -8.71% |
| 2006-12-31 | $29.22 M | 198.76% |
| 2005-12-31 | $9.78 M | 88818.18% |
| 2004-12-31 | $0.01 M | 0% |
| 2003-12-31 | $0.01 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.92 B | 2,006.52% | 🇺🇸 USA |
 Abbott Laboratories ABT | $16.84 B | 1,086.00% | 🇺🇸 USA |
 Medtronic MDT | $24.98 B | 1,658.80% | 🇮🇪 Ireland |
 Eli Lilly LLY | $18.82 B | 1,224.98% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | $0.41 B | -70.56% | 🇺🇸 USA |
 ICU Medical
ICUI | $1.63 B | 15.10% | 🇺🇸 USA |
 DexCom DXCM | $2.66 B | 87.34% | 🇺🇸 USA |